We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
+44%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$632M
AUM Growth
–
Cap. Flow
+$532M
Cap. Flow
% of AUM
84.29%
Top 10 Holdings %
Top 10 Hldgs %
78.2%
Holding
44
New
44
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$66.4M |
| 2 |
DCP
DCP Midstream, LP
DCP
|
+$64.6M |
| 3 |
Xerox
XRX
|
+$58.5M |
| 4 |
DURECT Corp
DRRX
|
+$54.6M |
| 5 |
Linde
LIN
|
+$38.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.38% |
| 2 | Energy | 20.11% |
| 3 | Industrials | 17.21% |
| 4 | Miscellaneous | 12.43% |
| 5 | Materials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RIBT
26
DELISTED
RiceBran Technologies
RIBT
| $2.94M | 0.47% |
+200,333
| New | +$4.72M |
2019 Q4
0 quarters
|
|
27
Cue Biopharma
CUE
$136M
| $2.62M | 0.41% |
+5,500
| New | +$1.73M |
2019 Q4
0 quarters
|
|
28
Blackstone
BX
$87.1B
| $2.24M | 0.35% |
+40,000
| New | +$2.08M |
2019 Q4
0 quarters
|
|
29
ReposiTrak
TRAK
$135M
| $2.21M | 0.35% |
+436,445
| New | +$2.24M |
2019 Q4
0 quarters
|
|
30
CareDx
CDNA
$3.45B
| $2.16M | 0.34% |
+100,000
| New | +$2.29M |
2019 Q4
0 quarters
|
|
31
Liberty Global Class C
LBTYK
$2.69B
| $1.52M | 0.24% |
+69,618
| New | +$1.57M |
2019 Q4
0 quarters
|
|
32
M&T Bank
MTB
$31.6B
| $1.19M | 0.19% |
+7,032
| New | +$1.14M |
2019 Q4
0 quarters
|
|
33
RTX Corp
RTX
$252B
| $899K | 0.14% |
+9,534
| New | +$865K |
2019 Q4
0 quarters
|
|
34
Atlanta Braves Holdings Series B
BATRK
$3.17B
| $612K | 0.1% |
+20,717
| New | +$589K |
2019 Q4
0 quarters
|
|
35
Liberty Global Class A
LBTYA
$2.74B
| $523K | 0.08% |
+22,989
| New | +$542K |
2019 Q4
0 quarters
|
|
|
INFI
36
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $480K | 0.08% |
+500,000
| New | +$549K |
2019 Q4
0 quarters
|
|
37
X4 Pharmaceuticals
XFOR
$262M
| $382K | 0.06% |
+1,191
| New | +$427K |
2019 Q4
0 quarters
|
|
38
L3Harris
LHX
$44.8B
| $317K | 0.05% |
+1,600
| New | +$321K |
2019 Q4
0 quarters
|
|
39
Atlanta Braves Holdings Series A
BATRA
$3.51B
| $307K | 0.05% |
+10,356
| New | +$295K |
2019 Q4
0 quarters
|
|
40
Voyager Therapeutics
VYGR
$127M
| $293K | 0.05% |
+21,029
| New | +$306K |
2019 Q4
0 quarters
|
|
41
Liberty Latin America Class C
LILAK
$1.6B
| $237K | 0.04% |
+14,212
| New | +$220K |
2019 Q4
0 quarters
|
|
|
LGF.B
42
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $163K | 0.03% |
+16,413
| New | +$142K |
2019 Q4
0 quarters
|
|
43
Sprott Physical Gold
PHYS
$14.9B
| $153K | 0.02% |
+12,540
| New | +$149K |
2019 Q4
0 quarters
|
|
44
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $99K | 0.02% |
+8,414
| New | +$141K |
2019 Q4
0 quarters
|
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Bleichroeder LP, which disclosed 44 positions worth $632M. Its ten largest holdings account for 78% of the portfolio.
Its largest position is SPDR Gold Trust: 475,000 shares worth $67.9M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, followed by Energy and Industrials.
- Bleichroeder LP's largest Q4 2019 buy was SPDR Gold Trust: 475,000 shares worth $67.9M.
- Bleichroeder LP's ten largest holdings make up 78% of its $632M portfolio in Q4 2019.
- Bleichroeder LP disclosed 44 positions in Q4 2019, its first 13F filing on record.
Based on Bleichroeder LP's 13F filing for Q4 2019, filed 14 Feb 2020.